The Prognostic Ability of RAS Pathway-Related Gene Mutations in Patients with Myeloid Neoplasms Treated with Hypomethylating Agents | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

The Prognostic Ability of RAS Pathway-Related Gene Mutations in Patients with Myeloid Neoplasms Treated with Hypomethylating Agents

Acta Haematol (2021) 144 (6): 649–659.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML

Elisabetta Metafuni
Viviana Amato
Sabrina Giammarco
Silvia Bellesi
Monica Rossi
Gessica Minnella
Filippo Frioni
Maria Assunta Limongiello
Livio Pagano
Andrea Bacigalupo
Simona Sica
Patrizia Chiusolo

Frontiers in Oncology (2022) 12